Ushbu ish iqtibos qilgan ishlar

15 ta ish

Ish: Nivolumab for recurrent cutaneous squamous cell carcinoma: three cases

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

   F. Stephen Hodi, Steven O’Day, David F. McDermott +26

   Maqola20109 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.121325

2. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

   Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22

   Maqola20153 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170111

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

   James Larkin, Vanna Chiarion‐Sileni, René González +28

   Maqola20152 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170114

4. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

   Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson +15

   Maqola20162 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170118

5. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170109

6. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170110

7. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170112

8. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170113

9. Sarlavhasiz

   Boshqa1 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.170115

10. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.170116

11. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.170117

12. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.170119

13. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.170120

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.170121

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.170122